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Abstract Bovine dopamine [~-monooxygenase has been assayed 
over a 10 000-fold range in protein concentration, to approximate 
conditions where the enzyme was shown to be a dimer or 
tetramer. Michaelis-Menten kinetics are observed with kea t and 
kcatlKm for dissociated enzyme reduced 30% and 200-300% 
relative to tetramer. Addition of chloride ions to very dilute 
enzyme or the use of intermediate enzyme concentrations causes 
non-Michaelis-Menten behavior, attributed to an equilibration 
between dimer and tetramer. This is not expected to contribute to 
activity within the chromaffin vesicle, where enzyme and chloride 
ions are at high levels. 
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1. Introduction 
Dopamine 13-monooxygenase (D~3M) and peptidylglycine c~- 
amidating enzyme (PAM) constitute a unique class of copper 
containing enzymes in higher eukaryotes that catalyze the 
oxidative production of hormones and neurotransmitters 
within their respective subcellular organelles [1,2]. The hy- 
droxylating domain of the bifunctional PAM (referred to as 
peptidylglycine c~-hydroxylating enzyme, PHM) shows a con- 
siderable sequence homology to positions 190 490 in D[3M 
[3,4]. A recent crystal structure for PHM indicates the posi- 
tion of the two active site coppers and their respective ligands, 
together with the location of conserved active site tyrosine 
residues [5]. While the active site structure of DI3M is assumed 
to be highly homologous to that of PHM, little information is 
currently available regarding the structure and function of the 
remaining ca. 50% of DI3M. 
Significant differences between DI3M and PAM include 
their oligomeric structure (DI3M is a dimer of dimers [1] while 
PAM is a bifunctional monomer [2]) and their sensitivity to 
regulation (only DI3M has shown to be activated by exoge- 
nous effectors, e.g. fumarate [6], and to give rise to apparent 
cooperativity in response to changing concentrations of ascot- 
bate [7] and amine substrates [8,9]). The apparent cooperative 
behavior of bovine D[3M as a function of the amine concen- 
tration was earlier proposed to arise from very large kinetic 
differences between the dimeric and tetrameric forms of pro- 
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tein and to play a role in the in vivo functioning of this 
enzyme [8,9]. In this report, we investigate the kinetic behav- 
ior of bovine D[3M over a 10000-fold range of protein con- 
centration, in order to characterize directly the behavior of the 
enzyme in its dissociated and associated forms. The resulting 
kinetic parameters, though not greatly different, are sufficient 
to generate deviations from Michaelis-Menten kinetics at in- 
termediate levels of protein. While the addition of chloride 
ions to dimeric enzyme produces a kinetic pattern analogous 
to intermediate protein levels, this does not occur when the 
enzyme is in its associated form. A model is proposed in 
which chloride ions induce association of DI3M. In the light 
of'the high levels of both DI3M [10 12] and chloride ions [13] 
in bovine adrenal chromaffin vesicles, DI3M is expected to be 
functional in its associated, tetrameric form. The absence of 
detectable fumarate ions within the chromaffin granules ar- 
gues against a role for this anion in the modulation of 
D[3M activity. 
2. Materials and methods 
2.1. Materials' 
Soluble and membranous D[3M was isolated as previously described 
[14]. All other materials were of reagent grade. 
2.2. Assay of enzyme activi O, 
Unless otherwise noted, all assay mixtures contained 50 mM 2-(N- 
morpholino) ethane sulfonic acid (MES) buffer, pH 6, 10 mM ascor- 
bate, 100 gg/ml catalase and tyramine hydrocbloride as a substrate 
source. No effects of added cupric ions were observed and it was 
omitted from assay mixtures. At intermediate protein concentrations, 
a continuous oxygen electrode assay was used, as previously described 
[14]. Although the reaction was initiated by the addition of enzyme, 
identical velocities were obtained upon pre-incubation of D[3M with 
the desired tyramine hydrochloride concentration a d initiation of the 
reaction with ascorbate, pH determinations of mock assay mixtures 
indicated a stable pH over the range of tyramine concentrations ex- 
amined. 
In order to assay the enzyme at very high (1 mg/ml) or very low 
(0.1 gg/ml) enzyme concentrations, a discontinuous HPLC/optical de- 
tection assay was employed [14]. We have previously shown our abil- 
ity to assay mg/ml evels of DI3M by a hand mixing device that allows 
data to be collected on a second time scale [15]. In control experi- 
ments, the continuous and discontinuous a say systems were shown to 
give similar results. Limiting kinetic parameters were obtained by 
non-linear fitting as described in [23]. 
2.3. Assay Jorfumarate ions in chromq~n granules 
Chromaffin vesicles were purified through a 1.6 M sucrose density 
gradient and stored as aliquots in 0.32 M sucrose at 78°C, as de- 
scribed [16]. An aliquot containing 1.2 ml of 12 mg/ml chromaffin 
granules (ca. 14 mg total protein) was thawed and suspended in 9 ml 
of 5 mM MES buffer, pH 6.0. After four freeze/thaw cycles, the 
sample was centrifuged at 14000 rpm. An equivalent volume of 
95% ethanol/10 mM H3PO4, pH 3.3, was added to the supernatant. 
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After 1 h at 4°C. the precipitated soluble protein was removed by 
centrifugation at 17 000 rpm tbr 30 min. The supernatant was con- 
centrated in vacuo to a volume of 2 ml, neutralized to pH 6.0 with 
NaOH and applied to a column (3 ml bed volume) of Dowex 
AG50WX (H + form, equilibrated in 10 mM phosphate, pH 6.0) for 
the removal of catecholamines. Components eluting in the void vol- 
ume which contained an optical density > 0.5 were pooled and con- 
centrated to 0.65 ml. Analysis of later fractions from the Dowex resin 
did not reveal the presence of any fumarate. Aliquots of this extract 
were injected onto a Phannacia Mono-Q anion exchange FPLC col- 
umn equilibrated in a running buffer of 20 mM piperazine, pH 5.0. A 
Shimadzu LC-6A/SPD-6A chromatograph/detector (A= 254 ran) and 
a C-R3A integrator system were employed for quantification of as- 
corbate and fumarate. 
3. Results and discussion 
3.1. Assay fi)r Jumarate in bovine a&enal chroma~n granules 
The fumarate ion has been reported to be the most potent 
in vitro anion activator of DI3M [17]. In order to understand 
the impact of anions on the in vivo behavior of DI3M, the 
level of fumarate in chromaffin vesicles was estimated. As 
described in Section 2, non-cationic, small molecule compo- 
nents from chromaffin granules were isolated and analyzed by 
FPLC. Shown in Fig. 1A are standard injections of ascorbate 
(5 nmol) and fumarate (5 nmol), where ascorbate lutes within 
10 rain after injection of the buffered sample and fumarate 
elutes 13.5 min after the beginning of a salt gradient. The 
ascorbate peak can provide an internal control during analysis 
of our chromaffin granule extracts, which were estimated in a 
separate xperiment to contain 1.5 mM ascorbate. At  the level 
of granular extract used in Fig. 1B, the first peak corresponds 
to ca. 75 nmol ascorbate. As can be seen, two new peaks are 
detected relative to ascorbate, which correspond to retention 
times for ADP (8 rain) and ATP (37 min). Importantly,  no 
fumarate peak was detected at its anticipated position of 
13.5 rain after the initiation of the salt gradient (40.5 min 
for the chromatogram in Fig. 1B). As a control, we were 
able to show that spiking diluted lysates with 100 BM fuma- 
rate, followed by precipitation of soluble proteins, removal of 
catecholamines and FPLC separation led to essentially full 
recovery of fumarate. F rom an estimated detection limit of 
ca. 0.2 nmol in a 50 B1 injection and a granular water content 
of 3 B1/mg [18,19], intravesicular fumarate is estimated to be 
< < 60 BM. Although early studies of D[3M activity indicated 
that 10 mM fumarate was required for full activation of the 
enzyme, a subsequent re-appraisal has led to values in the 
range of 100 gM (pH 5.5) 200 BM (pH 5.2) [7]. Thus, our 
level of detection for fumarate lies below the lowest levels yet 
reported for fumarate saturation, arguing against a role for 
fumarate in the in vivo activation of D[3M. 
3.2. Kinetic properties oJ DflM as a jhnction of the protein 
concentration i the absence of fumarate 
An assay of D[3M at changing levels of the substrate tyr- 
amine is shown to give rise to non-Michael is-Menten kinetics 
at intermediate protein concentrations (5 gg/ml), Fig. 2 (+). 
This type of deviation from linearity in Eadie-Hofstee plots 
has been seen previously and attr ibuted to an equil ibrating 
mixture of dimeric and tetrameric forms of D[3M [8,9]. If 
correct, an assay of enzyme in its pure dimeric and tetrameric 
forms is predicted to lead to normal Michael is-Menten ki- 
netics. We estimated that we could measure the steady state 





























Fig. 1. Assay for intravesicular fumarate. (A) Standard injection of 
ascorbate (5 nmol) and fumarate (5 nmol) to a Mono-Q anion ex- 
change FPLC column equilibrated in 20 mM piperazine, pH 5.0. A 
gradient containing 50 mM chloride was initiated at 13 min, with 
the fumarate peak eluting 13.5 min after the start of the gradient. 
The arrow indicates the beginning of the gradient. (B) 50 gl of the 
concentrated extract from the bovine adrenal chromaffin granules 
(see Section 2) was subjected to FPLC analysis under the conditions 
of A. The salt gradient begun at 27 min. No fumarate peak was de- 
tected at 40.5 rain. The arrow indicates the beginning of the gra- 
dient. 
concentrations (in the limits of 0.1 gg/ml and 1 mg/ml). These 
concentrations are expected to lead to enzyme solutions that 
are ca. 85% dimer and tetramer, respectively (using Kd = 10 7 
M (Ka = [E212/[E4]), from the ultracentrifugation experiments 
by Dhawan et al. [9]). 
As seen in Fig. 3, the assay of enzyme at 1 mg/ml produces, 
within the experimental error, a linear pattern and results in 
the values of kca t and ]Qat/K m summarized in Table 1. Not  





Fig. 2. Non-Michaelis-Menten kinetic behavior for D~3M. Velocities 
were determined in MES buffer, pH 6, with 0.2-8 mM tyramine at 
5 gg/ml of enzyme (+). In a second plot (11), the enzyme concentra- 
tion was 0.1 ~tg/ml and the chloride ion concentration was 50 mM. 
unexpectedly, addition of high concentrations of chloride ions 
(150 mM) leads to a marked decrease in the Km for substrate 
while retaining the linear character of the Eadie-Hofstee plot. 
This is due to the ability of high levels of monovalent ions to 
mimic the behavior of the fumarate ion, which has been 
shown to exert its primary effect on the reduction of Km for 
amine substrate [6]. 
In an analogous manner, enzyme was assayed at the very 
low concentration (0.1 gg/ml), leading to the linear pattern of 
Fig. 4 (11) and the kca  t and kcat/Km values of Table 1. It can be 
seen that kcat is reduced 30% and the k~t/Km is decreased 2 3- 
fold relative to tetramer. The trends in the measured param- 
eters (Table 1) are very different from values reported previ- 
ously for dimeric and tetrameric bovine adrenal D~M [8]. In 
the earlier study, kinetic parameters for extreme nzyme forms 
were derived from curve fitting of the non-Michaelis-Menten 
behavior of D[3M at intermediate protein concentrations. In 
this previous study, k~,t values were assumed to be identical 
and Km was calculated to differ by 50-fold (0.082 mM versus 
4.06 mM for dimer and tetramer). 
What can be the origin of the large difference between the 
computed Kn, values of Saxena et al. [8] and the direct anal- 
yses presented herein (Table 1)? The values of Saxena et al. 
were derived from a model in which the fraction of tetrameric 
Table 1 
Limiting kinetic parameters for dimeric and tetrameric D[3M :~ 
Enzyme kcat, s ] ko~t/Km, s ~ M ] 
Dimer 8.6 (+ 1.0) 1.8 (+0.5)X 103 
Tetramer 12.3 ( -+ 1.0) (13.8) b 4.4 (+ 1.1)× 103 (6.9× 103) b
aRate constants were calculated from initial velocities using a sub- 
unit molecular mass for enzyme of 75 000 g/mol. 
hThese values were used in the fitting of Eq. 1 to the data for 5 gg/ 
ml D[3M (+) in Fig. 2. 
enzyme was obtained from ultracentrifugation experiments 
and then assumed to exist in a fixed proportion at all sub- 
strate concentrations. However, as long as dimer and tetramer 
are characterized by greatly different differing Km values, the 
ratio of dimer to tetramer is expected to change with increas- 
ing substrate levels. In order to reproduce the data in this 
paper, we have used a model that assumes distinct values 
for the kcat and kcat/Km for dimer and tetramer (Table 1) 
and then allows the fractional tetramer concentration (FT) 
to vary with an increasing tyramine concentration: 
v (Vm,T[S]/Km,T + S) FT + (Vm,D[S]/Km,D + [SI)(I FT) 
(l) 
According to Eq. 1, Vm=V and Km,T are the maximal velocity 
and Michaelis constant for tetramer and V,,,,D and Km,D are 
the corresponding constants for dimer. We find that a very 
slight adjustment of the measured kinetic parameters for tet- 
ramer and dimer (cf. Table 1) can reproduce xactly the rela- 
tionship between the substrate concentration and measured 
velocities at a protein concentration of 5 gg/ml (Fig. 2 (+)) 
and for tyramine concentrations above 0.5 mM. Deviations 
are observed below 0.5 mM substrate and are tentatively at- 
tributed to the fact that experimentally determined velocities 
at tyramine < 0.2 mM were at the detection limit of the oxy- 
gen electrode. Importantly, relatively small changes in kcat and 
kcat/Km for dimer and tetramer are sufficient to produce the 
non-Michaelis-Menten behavior observed with bovine adrenal 
DI3M at an intermediate protein concentration. 
3.3. Effect of  chloride ions at a low protein eoncentration 
At 1 mg/ml protein, a high chloride ion concentration 
changes the Km for tyramine without influencing the linearity 
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Fig. 3. Michaelis-Menten kinetics at a high enzyme concentration. 
Velocities were measured at 1 mg/ml of D[3M. Initial rates deter- 
mined in MES buffer, pH 6, with 0.2-8 mM tyramine (11) and with 
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Fig. 4. Kinetic behavior at a low enzyme concentration. Velocities 
measured at 0.1 ~tg/ml of D[3M. Initial rates determined in MES 
buffer, pH 6, with 0.4 15 mM tyramine (11) and in the presence of 
15 mM chloride (+). 
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15 mM chloride ion to enzyme at 0.1 gg/ml converts a linear 
Eadie-Hofstee plot to one that shows deviation from Michae- 
lis-Menten behavior (Fig. 4 (+)). The simplest explanation for 
the differential effects of chloride ions on the kinetic behavior 
at very high versus very low protein concentrations is a chlor- 
ide-mediated association of dimer into tetrameric enzyme 
(such that the 0.1 gg/ml D[3M sample in the presence of 
chloride ions can no longer be approximated by a single en- 
zyme form). In fact, we can reproduce the behavior seen with 
5 gg/ml enzyme at 0.1 gg/ml by adding 50 mM chloride ions 
to the sample (Fig. 2 (m)). While the data presented in Figs. 2 
4 are for soluble D~3M, similar results were seen when these 
experiments were repeated using the membrane-attached form 
of enzyme (data not shown). 
3.4. Relevance to the in vivo behavior o f  Dt~M 
The nature of the regulation of D~M in vivo has come up 
previously in the context of the in vitro activating effects of 
fumarate [6] and ascorbate [7]. The finding from the present 
study of little or no fumarate within bovine adrenal chromaf- 
fin granules argues that this effect is not relevant o the in vivo 
functioning of D[3M. In the case of ascorbate, previous tudies 
in the absence of fumarate have shown the phenomenological 
properties of negative cooperativity, with 34- fo ld  increases in 
apparent kcat and Km values of ca. 0.05 0.10 mM (ascorbate 
<1 mM) and Km> 10 mM (very high ascorbate) [7]. The 
most likely explanation for this behavior is the ability of 
ascorbate to reduce both free enzyme (low ascorbate) and 
the enzyme product complex (high ascorbate) [7]. From a 
physiological perspective, levels of ascorbate are generally 
assumed to be high (ca. 20 raM) and fairly constant within 
chromaffin granules [20 22]. 
The data presented herein address the physiological rele- 
vance of the non-Michaelis-Menten behavior observed with 
regard to variation in the concentration of amine substrate 
([8,9] and Fig. 1). The two key observations from the present 
study are (i) the demonstration of normal Michaelis-Menten 
behavior at very high protein levels (Fig. 2) and (ii) the pro- 
posed conversion of dimeric to tetrameric D[3M in the pres- 
ence of added chloride (Figs. 2 and 4). Given previous esti- 
mates of total soluble D[3M within chromaffin granules of ca. 
1 2 mg/ml [10-12], together with estimates of the intragranu- 
lar chloride content of ca. 50 mM [13], we conclude that D[3M 
will exist in an associated state within mature chromaffin 
granules and, thus, will follow normal Michaelis-Menten ki- 
netics with high activity. This situation is likely to change 
upon the depletion of soluble intragranular components that 
accompanies exocytosis [1]. In this condition, the combined 
loss of anions, ascorbate and soluble DI3M from the chromaf- 
fin granule is expected to convert DI3M into a much less active 
form as the chromaffin granule undergoes recycling to the 
Golgi apparatus for re-packaging. 
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